tirzepatide kidney linked to lower risk for death, adverse CV and outcomes vs. GLP-1s Renal effects of GLP-1 receptor

Because three receptor systems are involved, reducing the dose to manage side effects may disproportionately affect one pathway more than others, leading to unpredictable changes in the benefit profile

The lean mass problem with GLP-1 receptor agonists is real and well-documented

Basic Clin Neurosci (2016) 7(2):13742

Repigmentation of gray hairs with lentigo maligna and response to topical imiquimod

Ipamorelin selectivity: Human pharmacology confirms selective GH release without cortisol, prolactin, or ACTH elevation at therapeutic doses (Raun et al., 1998)

Weight Loss available at Avere Beauty Theres a reason everyone is talking about it - it works